Bausch + Lomb Quarterly Cash Flow Statement
NYSE: BLCOHealth CareOphthalmic GoodsUSD
17.30+0.15 (+0.87%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch + Lomb free cash flow
In the quarter ended Jun 30, 2026, Bausch + Lomb generated $153.0 million of operating cash flow and spent $71.0 million on capital expenditures. That left free cash flow of $82.0 million, a free-cash-flow margin of 5.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch + Lomb cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -10.00M | -70.00M | -58.00M | -25.00M | -58.00M | -211.00M | -2.00M | 8.00M | -148.00M | -163.00M | -51.00M | -80.00M |
| Net Income growth (YoY) | — | — | — | -412.50% | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 102.00M | 101.00M | 99.00M | 109.00M | 107.00M | 106.00M | 106.00M | 110.00M | 110.00M | 110.00M | 116.00M | 82.00M |
| Stock-Based Compensation | 38.00M | 34.00M | 64.00M | 27.00M | 30.00M | 28.00M | 27.00M | 24.00M | 22.00M | 19.00M | 16.00M | 16.00M |
| Change in Working Capital | 19.00M | -46.00M | -67.00M | 37.00M | 48.00M | 0 | -182.00M | 98.00M | -14.00M | 11.00M | -100.00M | 0 |
| Operating Cash Flow | 153.00M | 32.00M | 136.00M | 137.00M | 35.00M | -25.00M | 22.00M | 154.00M | 15.00M | 41.00M | 15.00M | 48.00M |
| Capital Expenditures | -71.00M | -100.00M | -76.00M | -74.00M | -89.00M | -110.00M | -92.00M | -60.00M | -72.00M | -67.00M | -84.00M | -33.00M |
| Investing Cash Flow | -87.00M | -130.00M | -188.00M | -61.00M | -90.00M | -116.00M | -185.00M | -96.00M | -74.00M | -57.00M | -135.00M | -1.88B |
| Debt Issued | 84.00M | 2.80B | 136.00M | 0 | 3.17B | 50.00M | 506.00M | 0 | 50.00M | 75.00M | 96.00M | 1.98B |
| Debt Repaid | -35.00M | -2.81B | -19.00M | -7.00M | -3.06B | -10.00M | -357.00M | -8.00M | -7.00M | -58.00M | -7.00M | -141.00M |
| Financing Cash Flow | 34.00M | -20.00M | 116.00M | -12.00M | 90.00M | 31.00M | 146.00M | -20.00M | 40.00M | 12.00M | 86.00M | 1.81B |
| Net Change in Cash | 99.00M | -118.00M | 65.00M | 60.00M | 57.00M | -101.00M | -34.00M | 48.00M | -23.00M | -9.00M | -26.00M | -32.00M |
| Free Cash Flow | 82.00M | -68.00M | 60.00M | 63.00M | -54.00M | -135.00M | -70.00M | 94.00M | -57.00M | -26.00M | -69.00M | 15.00M |
This table shows 12 quarterly periods of Bausch + Lomb's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BLCO's reporting calendar. What is a cash flow statement?